Krystal Biotech
KRYS
KRYS
194 hedge funds and large institutions have $3.07B invested in Krystal Biotech in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 72 increasing their positions, 66 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
194
Holders Change
+6
Holders Change %
+3.19%
% of All Funds
2.84%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.07%
New
29
Increased
72
Reduced
66
Closed
20
Calls
$57.9M
Puts
$97.6M
Net Calls
-$39.7M
Net Calls Change
-$23.7M
Top Buyers
| 1 |
Jennison Associates
New York
|
$89.9M |
| 2 |
Morgan Stanley
New York
|
$79.3M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
$58.9M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
$31.8M |
| 5 |
State Street
Boston,
Massachusetts
|
$154M |
